These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24433798)

  • 1. [Pathogenesis and treatment strategies of drug-induced liver injury].
    Chen CW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):726-8. PubMed ID: 24433798
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of liver protection drugs in patients with anti-tuberculosis therapy induced liver injury].
    Miao XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):729-31. PubMed ID: 24433799
    [No Abstract]   [Full Text] [Related]  

  • 3. [Danger of liver damage in modern antitubercular treatment].
    Kozma D; Lapis K; Debreczeni L
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():479-81. PubMed ID: 6647279
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinic and pathogenesis of drug hepatitis].
    Mardare G
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(1):43-5. PubMed ID: 25591247
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rational use of hepato-protectants in the prophylaxis and treatment of anti-tuberculosis drug-induced hepatotoxicity].
    Gu J; Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):767-9. PubMed ID: 24433806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Debate on the prophylactic application of hepatoprotectants during anti-tuberculosis treatment].
    Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):722-3. PubMed ID: 24433796
    [No Abstract]   [Full Text] [Related]  

  • 7. [Updated progress on the pathogenesis of liver injury induced by anti-tuberculosis drugs].
    Yang S; Guo JQ; Yan XF
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 May; 42(5):378-381. PubMed ID: 31137115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hepatoprotective activity of remaxol and S-adenosyl-L-methionine for liver damage caused by reserve-series antituberculosis drugs].
    Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML
    Arkh Patol; 2013; 75(2):25-9. PubMed ID: 24006761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of antituberculosis drugs.
    Mohan A; Sharma SK
    Am J Respir Crit Care Med; 2004 Apr; 169(7):882-3. PubMed ID: 15044223
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paying attention to the prevention and treatment of hepatic injury induced by anti-tuberculosis drugs].
    Tan SY
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 May; 42(5):326-329. PubMed ID: 31137107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
    Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
    Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculous therapy and acute liver function.
    FitzGerald JM
    Lancet; 1995 May; 345(8958):1172. PubMed ID: 7723558
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H
    Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
    Can Commun Dis Rep; 2001 Jul; 27(13):114-6. PubMed ID: 11443837
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatoprotective effect of rhinax on antitubercular drug-induced hepato-toxicity in rats.
    Dhuley JN
    Hindustan Antibiot Bull; 2002; 44(1-4):53-9. PubMed ID: 15061596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver injury under tuberculostatic treatment].
    Fattinger K; Braunschweig S; Reichen J; Meier-Abt PJ; Krähenbühl S
    Praxis (Bern 1994); 1997 Apr; 86(15):626-9. PubMed ID: 9213916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological activity of runihol and S-adenosyl-L-methionine in rats with experimental liver damage by reserve antituberculosis drugs].
    Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Okovityĭ SV; Vasil'eva SN; Vitovskaia ML
    Eksp Klin Farmakol; 2013; 76(9):27-31. PubMed ID: 24432566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between two strategies for monitoring hepatic function during antituberculous therapy.
    Singanayagam A; Sridhar S; Dhariwal J; Abdel-Aziz D; Munro K; Connell DW; George PM; Molyneaux PL; Cooke GS; Burroughs AK; Lalvani A; Wickremasinghe M; Kon OM
    Am J Respir Crit Care Med; 2012 Mar; 185(6):653-9. PubMed ID: 22198973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low N-acetyltransferase 2 activity in isoniazid-associated acute hepatitis requiring liver transplantation.
    Cramer JP; Lohse AW; Burchard GD; Fischer L; Nashan B; Zimmermann M; Marx A; Kluge S
    Transpl Int; 2010 Feb; 23(2):231-3. PubMed ID: 19686464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-induced hepatitis. Local monitoring criteria].
    Rossini L; Leone L
    Minerva Med; 1980 Nov; 71(47):3455-61. PubMed ID: 6161323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.